Cargando…
Predictive model for recurrence of renal cell carcinoma by comparing pre‐ and postoperative urinary metabolite concentrations
To improve treatment outcomes in real practice, useful biomarkers are desired when predicting postoperative recurrence for renal cell carcinoma (RCC). We collected data from patients who underwent definitive surgery for RCC and for benign urological tumor at our department between November 2016 and...
Autores principales: | Morozumi, Kento, Kawasaki, Yoshihide, Maekawa, Masamitsu, Takasaki, Shinya, Sato, Tomonori, Shimada, Shuichi, Kawamorita, Naoki, Yamashita, Shinichi, Mitsuzuka, Koji, Mano, Nariyasu, Ito, Akihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748223/ https://www.ncbi.nlm.nih.gov/pubmed/34710258 http://dx.doi.org/10.1111/cas.15180 |
Ejemplares similares
-
Accurate quantification of urinary metabolites for predictive models manifest clinicopathology of renal cell carcinoma
por: Sato, Tomonori, et al.
Publicado: (2020) -
Metabolomic Analysis to Elucidate Mechanisms of Sunitinib Resistance in Renal Cell Carcinoma
por: Sato, Tomonori, et al.
Publicado: (2020) -
Severe toxicity induced by accumulation of active sunitinib metabolite in a Japanese patient with renal cell carcinoma: a case report
por: Takasaki, Shinya, et al.
Publicado: (2017) -
Phosphodiesterase type 5 inhibitor administered immediately after radical prostatectomy temporarily increases the need for incontinence pads, but improves final continence status
por: Kaiho, Yasuhiro, et al.
Publicado: (2016) -
Combination Therapy of Pembrolizumab plus Axitinib for a Patient on Hemodialysis with Metastatic Renal Cell Carcinoma: A Case Report
por: Katsumata, Yuki, et al.
Publicado: (2021)